Long-term treatment with oxcarbazepine in clinical practice

Functional Neurology

Volumn 20, Issue 3, 2005, Pages 131-133

  Passarella, Bruno ^a   Nozzoli, Cecilia ^a  

^a PERRINO HOSPITAL   (Italy)

Author keywords

Epilepsy; Long term; Oxcarbazepine; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; HYDANTOIN; OXCARBAZEPINE; PHENOBARBITAL; VALPROIC ACID;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DIPLOPIA; DIZZINESS; DOSE RESPONSE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG TOLERANCE; EPILEPSY; FEMALE; GLOSSITIS; HUMAN; HYPONATREMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TREATMENT WITHDRAWAL;

ADOLESCENT; ADULT; ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 30644476238     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. French JA, Kanner AM, Bautista J et al. Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsy. Neurology 2004;62:1252-1260
2. French JA, Kanner AM, Bautista J et al. Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy. Neurology 2004;62:1261-1273
3. National Institute for Clinical Excellence. Newer drugs for epilepsy in adults. www.nice.org.uk
4. National Institute for Clinical Excellence. Newer drugs for epilepsy in children. www.nice.org.uk
5. Beghi E. Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines. Lancet Neurol 2004;3:618-621
6. McCorry D, Chadwick D, Marson A. Current drug treatment of epilepsy in adults. Lancet Neurol 2004;3:729-735
7. LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. JAMA 2004;291:605-614
8. Wellington K, Goa KL. Oxcarbazepine: an update of its efficacy in the management of epilepsy. CNS Drugs 2001; 15:137-163
9. Kutluay E, McCague K, D'Souza J, Beydoun A. Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav 2003;4:175-180
10. Beydoun A, Sachdeo RC, Kutluay E, McCague K, D'Souza J. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy. Epilepsia 2003;44:1160-1165
11. French JA, Wallace SJ. Clinical trials of antiepileptic drugs in adults and children. In: Engel J, Pedley TA eds Epilepsy: A Comprehensive Textbook. Philadelphia; Lippincott-Raven 1997:1435-1443
12. Shorvon S. Handbook of Epilepsy Treatment. Oxford; Blackwell Sciences 2000:2:16
13. Shouse M, Martins da Silva A. Chronobiology. In: Engel J, Pedley TA eds Epilepsy: A Comprehensive Textbook. Philadelphia; Lippincott-Raven 1997:1918-1919
14. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-319